Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 379

1.

Comprehensive analysis of type 1 fimbriae regulation in fimB-null strains from the multidrug resistant Escherichia coli ST131 clone.

Sarkar S, Roberts LW, Phan MD, Tan L, Lo AW, Peters KM, Paterson DL, Upton M, Ulett GC, Beatson SA, Totsika M, Schembri MA.

Mol Microbiol. 2016 Jun 16. doi: 10.1111/mmi.13442. [Epub ahead of print]

PMID:
27309594
2.

Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.

Bergen PJ, Bulitta JB, Kirkpatrick CM, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Lipman J, Roberts JA, Landersdorfer CB.

J Antimicrob Chemother. 2016 May 26. pii: dkw153. [Epub ahead of print]

PMID:
27231278
3.

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

van Duin D, Paterson DL.

Infect Dis Clin North Am. 2016 Jun;30(2):377-90. doi: 10.1016/j.idc.2016.02.004. Review.

PMID:
27208764
4.

Re-activation of varicella zoster virus associated with anterior spinal cord stroke in pregnancy.

McNamara JF, Paterson DL, Allworth A, Presneill J, O'Connell P, Henderson RD.

Infect Dis (Lond). 2016 Sep;48(9):705-7. doi: 10.1080/23744235.2016.1185535. Epub 2016 May 20. No abstract available.

PMID:
27207607
5.

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.

Gutiérrez-Gutiérrez B, Pérez-Galera S, Salamanca E, de Cueto M, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina J, Hernández A, Venditti M, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Natera C, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4159-69. doi: 10.1128/AAC.00365-16. Print 2016 Jul.

PMID:
27139473
6.

Mechanisms Involved in Acquisition of blaNDM Genes by IncA/C2 and IncFIIY Plasmids.

Wailan AM, Sidjabat HE, Yam WK, Alikhan NF, Petty NK, Sartor AL, Williamson DA, Forde BM, Schembri MA, Beatson SA, Paterson DL, Walsh TR, Partridge SR.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4082-8. doi: 10.1128/AAC.00368-16. Print 2016 Jul.

PMID:
27114281
7.

General Practitioner Antimicrobial Stewardship Programme Study (GAPS): protocol for a cluster randomised controlled trial.

Avent ML, Hansen MP, Gilks C, Del Mar C, Halton K, Sidjabat H, Hall L, Dobson A, Paterson DL, van Driel ML.

BMC Fam Pract. 2016 Apr 21;17:48. doi: 10.1186/s12875-016-0446-7.

8.

CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.

Tong SY, Nelson J, Paterson DL, Fowler VG Jr, Howden BP, Cheng AC, Chatfield M, Lipman J, Van Hal S, O'Sullivan M, Robinson JO, Yahav D, Lye D, Davis JS; CAMERA2 study group and the Australasian Society for Infectious Diseases Clinical Research Network.

Trials. 2016 Mar 31;17(1):170. doi: 10.1186/s13063-016-1295-3.

9.

Laboratory-based surveillance of Clostridium difficile circulating in Australia, September - November 2010.

Cheng AC, Collins DA, Elliott B, Ferguson JK, Paterson DL, Thean S, Riley TV.

Pathology. 2016 Apr;48(3):257-60. doi: 10.1016/j.pathol.2016.02.005. Epub 2016 Mar 2.

PMID:
27020502
10.

Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site stepped-wedge randomised trial.

Hall L, Farrington A, Mitchell BG, Barnett AG, Halton K, Allen M, Page K, Gardner A, Havers S, Bailey E, Dancer SJ, Riley TV, Gericke CA, Paterson DL, Graves N.

Implement Sci. 2016 Mar 24;11:44. doi: 10.1186/s13012-016-0406-6.

11.

Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies.

Furuya-Kanamori L, Doi SA, Paterson DL, Helms SK, Yakob L, McKenzie SJ, Garborg K, Emanuelsson F, Stollman N, Kronman MP, Clark J, Huber CA, Riley TV, Clements AC.

J Clin Gastroenterol. 2016 Mar 11. [Epub ahead of print]

PMID:
26974758
12.

Genotypic and phenotypic identification of Aeromonas species and CphA-mediated carbapenem resistance in Queensland, Australia.

Sinclair HA, Heney C, Sidjabat HE, George NM, Bergh H, Anuj SN, Nimmo GR, Paterson DL.

Diagn Microbiol Infect Dis. 2016 May;85(1):98-101. doi: 10.1016/j.diagmicrobio.2016.02.005. Epub 2016 Mar 10.

PMID:
26971634
13.

Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.

Gutiérrez-Gutiérrez B, Bonomo RA, Carmeli Y, Paterson DL, Almirante B, Martínez-Martínez L, Oliver A, Calbo E, Peña C, Akova M, Pitout J, Origüen J, Pintado V, García-Vázquez E, Gasch O, Hamprecht A, Prim N, Tumbarello M, Bou G, Viale P, Tacconelli E, Almela M, Pérez F, Giamarellou H, Cisneros JM, Schwaber MJ, Venditti M, Lowman W, Bermejo J, Hsueh PR, Mora-Rillo M, Gracia-Ahulfinger I, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Group.

J Antimicrob Chemother. 2016 Jun;71(6):1672-80. doi: 10.1093/jac/dkv502. Epub 2016 Feb 22.

PMID:
26907184
14.

Molecular Comparison of Bacterial Communities on Peripheral Intravenous Catheters and Matched Skin Swabs.

Choudhury MA, Marsh N, Banu S, Paterson DL, Rickard CM, McMillan DJ.

PLoS One. 2016 Jan 5;11(1):e0146354. doi: 10.1371/journal.pone.0146354. eCollection 2016.

15.

25-Hydroxyvitamin D Concentrations and Clostridium difficile Infection: A Meta-Analysis.

Furuya-Kanamori L, Wangdi K, Yakob L, McKenzie SJ, Doi SA, Clark J, Paterson DL, Riley TV, Clements AC.

JPEN J Parenter Enteral Nutr. 2015 Dec 23. pii: 0148607115623457. [Epub ahead of print]

PMID:
26701764
16.

Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?

Nation RL, Garonzik SM, Li J, Thamlikitkul V, Giamarellos-Bourboulis EJ, Paterson DL, Turnidge JD, Forrest A, Silveira FP.

Clin Infect Dis. 2016 Mar 1;62(5):552-8. doi: 10.1093/cid/civ964. Epub 2015 Nov 25.

PMID:
26607424
17.

Colistin resistance: a major breach in our last line of defence.

Paterson DL, Harris PN.

Lancet Infect Dis. 2016 Feb;16(2):132-3. doi: 10.1016/S1473-3099(15)00463-6. Epub 2015 Nov 19. No abstract available.

PMID:
26603171
18.

Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications.

Furuya-Kanamori L, Marquess J, Yakob L, Riley TV, Paterson DL, Foster NF, Huber CA, Clements AC.

BMC Infect Dis. 2015 Nov 14;15:516. doi: 10.1186/s12879-015-1258-4. Review.

19.

Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.

Harris PN, Wei JY, Shen AW, Abdile AA, Paynter S, Huxley RR, Pandeya N, Doi Y, Huh K, O'Neal CS, Talbot TR, Paterson DL.

J Antimicrob Chemother. 2016 Feb;71(2):296-306. doi: 10.1093/jac/dkv346. Epub 2015 Nov 4.

PMID:
26542304
20.

Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and Their blaNDM Genetic Contexts.

Wailan AM, Paterson DL, Kennedy K, Ingram PR, Bursle E, Sidjabat HE.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):136-41. doi: 10.1128/AAC.01243-15.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk